Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Surgepays Q2 EPS $(0.36) Misses $(0.20) Estimate, Sales $11.518M Miss $16.137M Estimate

Author: Benzinga Newsdesk | August 13, 2025 03:12pm
Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.20) by 84.62 percent. This is a 45.45 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $11.518 million which missed the analyst consensus estimate of $16.137 million by 28.62 percent. This is a 23.65 percent decrease over sales of $15.086 million the same period last year.

Posted In: SURG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist